NIH-funded research R21 grant

Understanding how a specific bacterium regulates its biofilm formation

Official title: Exopolysaccharide regulation in Aggregatibacter actinomycetemcomitans

Funded at Rutgers Biomedical and Health Sciences · NIH-10862078 · Data updated 2026-11-12

This study is looking at how a specific bacteria in your mouth, which can cause infections, makes a substance that helps it stick around and cause problems, with the hope of finding new ways to treat those infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 18, 2024
Project endSeptember 17, 2026
Funding year2024
Award (this year)$431,750
NIH project number1R21DE033781-01
Project IDNIH-10862078 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with oral infections or periodontal disease linked to Aggregatibacter actinomycetemcomitans.

Less likely to help

Patients without oral infections or those not affected by Aggregatibacter actinomycetemcomitans may not receive any benefit from this research.

What this research studies

This research investigates the regulation of exopolysaccharides (EPS) in the oral bacterium Aggregatibacter actinomycetemcomitans, which is known for its ability to form biofilms that contribute to oral infections. The study aims to uncover the mechanisms behind EPS production and its role in the bacterium's virulence and survival in the oral environment. By exploring the regulation of EPS, the research seeks to identify potential targets for therapeutic intervention. Patients may benefit from insights that could lead to improved treatments for infections caused by this bacterium.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating infections associated with Aggregatibacter actinomycetemcomitans.

How similar studies have gone: While the regulation of EPS in other bacteria has been studied, the specific mechanisms in Aggregatibacter actinomycetemcomitans are less understood, making this research a novel exploration.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Ramasubbu, Narayanan — Rutgers Biomedical and Health Sciences
  • Study coordinator: Ramasubbu, Narayanan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.